Clinical Trial Update: Interleukin-12 and Interferon Alfa in Treating Patients With Metastatic Kidney Cancer or Malignant Melanoma [Phase 1]

View source ↗

Summary

Phase 1 clinical trial evaluating the combination of Interleukin-12 and Interferon alfa in patients with metastatic renal cell carcinoma and melanoma; the study…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Melanoma
• Renal Cell Carcinoma

Drugs mentioned

• Interferon Alfa (interferon alfa)
• Interleukin-12 (interleukin-12)

Snippet

Sponsor: National Cancer Institute (NCI) | Conditions: Kidney Cancer, Melanoma (Skin) | Phase 1 | Status: COMPLETED